Disease progression in myelodysplastic syndromes: do mesenchymal cells pave the way?
- PMID: 24905157
- DOI: 10.1016/j.stem.2014.05.010
Disease progression in myelodysplastic syndromes: do mesenchymal cells pave the way?
Abstract
Early events driving the initiation and evolution of neoplasms remain poorly defined but involvement of an instructive or permissive niche has been implicated. In this issue of Cell Stem Cell, Medyouf et al. (2014) provide insights into the role of the niche in myelodysplastic syndromes, the principle preleukemic disorder of the hematopoietic system.
Copyright © 2014 Elsevier Inc. All rights reserved.
Comment on
-
Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit.Cell Stem Cell. 2014 Jun 5;14(6):824-37. doi: 10.1016/j.stem.2014.02.014. Epub 2014 Apr 3. Cell Stem Cell. 2014. PMID: 24704494
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
